Influence of the surface on thrombin generation

International Journal of Laboratory Hematology

Volumn 30, Issue 4, 2008, Pages 269-277

  Stief, T W ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Coagulation activation; Hemolysis; Plastic; Polystyrol; Thrombin

Indexed keywords

APROTININ; ARGININE; HEMOGLOBIN; POLYSTYRENE; THROMBIN; TRYPSIN INHIBITOR;

ARTICLE; BIOASSAY; BLOOD CLOTTING TIME; BLOOD VESSEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE; ERYTHROCYTE; HUMAN; PLASMA; PRIORITY JOURNAL; SURFACE PROPERTY; THROMBIN TIME; BLOOD CLOTTING TEST; HEMOLYSIS; METHODOLOGY;

BLOOD COAGULATION TESTS; HEMOLYSIS; HUMANS; THROMBIN;

EID: 53449100488     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2007.00959.x     Document Type: Article

References (29)

1. Arvidsson S., Askendal A. & Tengvall P. (2007) Blood plasma contact activation on silicon, titanium and aluminium. Biomaterials 28, 1346-1354.
2. Bartels P.C., Schoorl M., Schoorl M. & Nube M.J. (2003) Deviations in coagulation activation due to treatment with different haemodialysis membranes. Scandinavian Journal of Clinical and Laboratory Investigation 63, 417-424.
3. Boisson C., Gulino D. & Jozefonvicz J. (1987) Affinity of antithrombin III for insoluble modified polystyrene. Thrombosis Research 46, 101-108.
4. Bonomini M., Sirolli V., Merciaro G., Antidormi T., Di Liberato L., Brummer U., Papponetti M., Cappelli P., Di Gregorio P. & Arduini A. (2005) Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine. Nephrology, Dialysis, Transplantation 20, 361-366.
5. Charef S., Jozefowicz M., Labarre D., Tapon-Bretaudiere J., Fischer A.M. & Bros A. (1990) Plasmatic antiproteinase activity enhancement by insoluble functionalized polystyrene surfaces. Biomaterials 11, 425-429.
6. Chu A.J., Beydoun S., Mathews S.T. & Hoang J. (2003) Novel anticoagulant polyethylenimine: inhibition of thrombin-catalyzed fibrin formation. Archives of Biochemistry and Biophysics 415, 101-108.
7. Davenport A. (2006) Anticoagulation options for intermittent haemodialysis. Minerva Urologica e Nefrologica 58, 171-180.
8. Du Toit H.J., Coetzee A.R. & Chalton D.O. (1991) Heparin treatment in thrombininduced disseminated intravascular coagulation in the baboon. Critical Care Medicine 19, 1195-1200.
9. Ewald G.A. & Eisenberg P.R. (1995) Plasmin-mediated activation of contact system in response to pharmacological thrombolysis. Circulation 91, 28-36.
10. Fischer A.M., Yu X.J., Tapon-Bretaudiere J., Muller D., Bros A. & Jozefonvicz J. (1986) Thrombin purification by onestep preparative affinity chromatography on modified polystyrenes. Journal of Chromatography 363, 95-100.
11. Fuhrer G., Gallimore M.J., Heller W. & Hoffmeister H.E. (1992) Aprotinin in cardiopulmonary bypass-effects on the Hageman factor (FXII)-Kallikrein system and blood loss. Blood Coagulation and Fibrinolysis 3, 99-104.
12. Grunkemeier J.M., Tsai W.B. & Horbett T.A. (1998) Hemocompatibility of treated polystyrene substrates: contact activation, platelet adhesion, and procoagulant activity of adherent platelets. Journal of Biomedical Materials Research 41, 657-670.
13. Hong J., Larsson A., Ekdahl K.N., Elgue G., Larsson R. & Nilsson B. (2001) Contact between a polymer and whole blood: sequence of events leading to thrombin generation. Journal of Laboratory and Clinical Medicine 138, 139-145.
14. Kratz A., Stanganelli N. & Van Cott E.M. (2006) A comparison of glass and plastic blood collection tubes for routine and specialized coagulation assays: a comprehensive study. Archives of Pathology and Laboratory Medicine 130, 39-44.
15. Lin W.C., Tseng C.H. & Yang M.C. (2005) In-vitro hemocompatibility evaluation of a thermoplastic polyurethane membrane with surface-immobilized water-soluble chitosan and heparin. Macromolecular Bioscience 5, 1013-1021.
16. Mahoney W.C., Hermodson M.A., Jones B., Powers D.D., Corfman R.S. & Reeck G.R. (1984) Amino acid sequence and secondary structural analysis of the corn inhibitor of trypsin and activated hageman factor. Journal of Biological Chemistry 259, 8412-8416.
17. Mastroroberto P., Chello M., Zofrea S. & Marchese A.R. (1995) Suppressed fibrinolysis after administration of low-dose aprotinin: reduced level of plasmin-alpha2-plasmin inhibitor complexes and postoperative blood loss. European Journal of Cardio-Thoracic Surgery 9, 143-145.
18. Monien B.H., Cheang K.I. & Desai U.R. (2005) Mechanism of poly(acrylic acid) acceleration of antithrombin inhibition of thrombin: implications for the design of novel heparin mimics. Journal of Medicinal Chemistry 48, 5360-5368.
19. Monien B.H. & Desai U.R. (2005) Antithrombin activation by nonsulfated, non-polysaccharide organic polymer. Journal of Medicinal Chemistry 48, 1269-1273.
20. Mosesson M.W. (2003) Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation. Thrombosis and Haemostasis 89, 9-12.
21. van Oeveren W., Haan J., Lagerman P. & Schoen P. (2002) Comparison of coagulation activity tests in vitro for selected biomaterials. Artificial Organs 26, 506-511.
22. Rollason G. & Sefton M.V. (1992) Measurement of the rate of thrombin production in human plasma in contact with different materials. Journal of Biomedical Materials Research 26, 675-693.
23. Stief T.W. (2006a) Specific determination of plasmatic thrombin activity. Clinical and Applied Thrombosis/Hemostasis 12, 324-329.
24. Stief T.W. (2006b) Thrombin generation by exposure of blood to endotoxin: a simple model to study disseminated intravascular coagulation. Clinical and Applied Thrombosis/Hemostasis 12, 137-161.
25. Stief T.W. (2006c) Inhibition of intrinsic thrombin generation. Drug Target Insights 2, 6-11.
26. 2x test: the corrected chi-square comparison against the control-mean. Clinical and Applied Thrombosis/Hemostasis 13, 73-100.
27. Stief T.W. (2007b) The recalcified coagulation activity assay. Clinical and Applied Thrombosis/Hemostasis (in press)
28. Tamada Y., Murata M., Hayashi T. & Goto K. (2002) Anticoagulant mechanism of sulfonated polyisoprenes. Biomaterials 23, 1375-1382.
29. Yoshizaki T., Tabuchi N., van Oeveren W., Shibamiya A., Koyama T. & Sunamori M. (2005) PMEA polymer-coated PVC tubing maintains anti-thrombogenic properties during in vitro whole blood circulation. International Journal of Artificial Organs 28, 834-840.